AI assistant
Sending…
Xylem Inc. — Director's Dealing 2011
Nov 3, 2011
30109_dirs_2011-11-03_5217e5be-e33e-424e-aa13-b30a71b82fc7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Xylem Inc. (XYL)
CIK: 0001524472
Period of Report: 2011-11-01
Reporting Person: McClain Gretchen W (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-11-01 | Common Stock | A | 70736 | $0.00 | Acquired | 155292 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-11-01 | Employee Stock Option (Right to Buy) | $31.21 | A | 59374 | Acquired | 2012-09-19 | Common Stock (59374) | Direct |
| 2011-11-01 | Employee Stock Option (Right to Buy) | $29.57 | A | 15541 | Acquired | 2013-03-06 | Common Stock (15541) | Direct |
| 2011-11-01 | Employee Stock Option (Right to Buy) | $32.56 | A | 26994 | Acquired | 2014-03-07 | Common Stock (26994) | Direct |
| 2011-11-01 | Employee Stock Option (Right to Buy) | $29.81 | A | 29693 | Acquired | 2015-03-10 | Common Stock (29693) | Direct |
| 2011-11-01 | Employee Stock Option (Right to Buy) | $18.63 | A | 53669 | Acquired | 2016-03-05 | Common Stock (53669) | Direct |
| 2011-11-01 | Employee Stock Option (Right to Buy) | $30.03 | A | 42837 | Acquired | 2020-03-05 | Common Stock (42837) | Direct |
| 2011-11-01 | Employee Stock Option (Right to Buy) | $32.38 | A | 59598 | Acquired | 2021-03-03 | Common Stock (59598) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 123 | Indirect |
Footnotes
F1: The total amount of securities beneficially owned following the reported transactions includes securities that were received in connection with the spin-off of Xylem Inc. from ITT Corporation in a transaction that was exempt from reporting under Rule 16a-9 under the Securities Exchange Act of 1934.
F2: As of November 1, 2011.
F3: These options are fully vested and exercisable.
More from Xylem Inc.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Mar 30
Director's Dealing
2026
Mar 3